Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioMarin Pharmaceutical Inc. buy Evercore ISI

Start price
€62.80
30.10.24 / 50%
Target price
€96.68
30.10.25
Performance (%)
-28.54%
End price
€44.88
31.10.25
Summary
This prediction ended on 31.10.25 with a price of €44.88. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -28.54%. Evercore_ISI has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioMarin Pharmaceutical Inc. -1.003% -1.003% -27.776%
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

Comments by Evercore_ISI for this prediction

In the thread BioMarin Pharmaceutical Inc. diskutieren
Prediction Buy
Perf. (%) -28.54%
Target price 96.684
Change
Ends at 30.10.25

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Evercore ISI from $115.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat

In the thread Trading BioMarin Pharmaceutical Inc.
Prediction Buy
Perf. (%) -28.54%
Target price 96.684
Change
Ends at 30.10.25

Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten